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intermediate in non-Met30 ATTR, and minimal in Met30-related ATTR. Vascular deposi- 
tion is far more frequent in AL than in ATTR. 
leftventricularfunction. 
Results: 
1160-76 Pacemakers and Defibrillators in Patients With Cardiac 
Sarcoidosis 
Allen J. Solomon Henry Yeager, Jr., Cynthia M. Tracy, Georgetown University Hospital, 
Washington, DC 
Background: The prognosis associated wtth cardiac sarcoidosis remains controversial. 
Additionally, the use of pacemakers (PM) and defibrillators (ICD) in this population has 
not been fully evaluated. Mathods: We describe 10 consecutive patients (9 women; 7 
African Americans; mean age 51 f 11 years) with biopsy-proven systemic sarcoidosis 
and presumed sarcoid of the heart. All patients had a PM and/or an ICD. Results: These 
patients had a mean left ventricular ejection fraction (LVEF) of 0.58 * 0.09 (0.58 * 0.05 in 
the ventricular tachycardia (VT) population) and have carried a diagnosis of cardiac sar- 
coidosis for 80 * 38 months. The indications for device implantation were complete heart 
block in 6 patients, sustained VT in 2 patients, and both complete heart block and VT in 2 
patients. In addition, 4 patients had paroxysmal atrial flutter. As a result of these arrhyth- 
mias, 6 patients received a PM, 3 patients received an ICD, and one patient had both a 
PM and an ICD. For patients with a PM, the initial pacing and sensing thresholds were 
excellent and did not change significantly over a mean follow-up of 80 months. For ICD 
patients, the defibrillation threshold at implant was 16.5 * 6.6 joules. One ICD patient 
received multiple appropriate ICD shocks for VT, while the other three patients have had 
no recurrent VT. All patients are currently alive and asymptomatic from a cardiac stand- 
point. Conclusions: (1) The prognosis for device patients with cardiac sarcoidosis is 
often very good and better than portrayed in the earlier literature. (2) Both PM’s and 
ICD’s function appropriately in this population, despite the infiltrative cardiomyopathy. (3) 
VT patients often have preserved systolic function. (4) The clinical course frequently sta- 
bilizes over time. 
The 3 patients with active. untreated extracardiac sarcoidosis showed regions with 
patchy increased signal intensity due to local inflammation. In these regions systolic 
myocardial wall thickening was decreased. After treatment with steroids in 2 patients, fol- 
low up studies showed a decrease of these patchy abnormalittes. In the 16 patients who 
had received treatment with steroids, no regions with increased signal intensity where 
observed. These patients had a normal systolic LV function. 
Conclusion: 
Contrast enhanced magnetic resonance imaging can demonstrate myocardial involve- 
ment in sarcoidosis. and be used to monitor the effect of initiated treatment. 
1160-81 Elevated Serum Troponin Levels Predict Short-Term 
Mortality in Patients With Systemic Amyloidosis 
Wavne L. Miller, Angela Dispenzieri, Allan S. Jaffe, Krishnaswamy Chandrasekaran. 
Joseph P. McConnell, Mary F. Burritt. Mayo Clinic, Rochester, MN 
Background: The development of heart failure symptoms in systemic amyloidosis sug- 
gests advanced disease and a poor prognosis. Absent overt heart failure, echo parame- 
ters have often been used to determine prognosis. We hypothesized that the cardiac 
troponin T and I (cTnT, cTnl) which are sensitive and specific blomarkers of myocardial 
injury might predict early cardiac involvement and provide improved risk stratification. 
Methods: between April 1979 and November 2000, 266 patients with a tissue diagnosis 
of AL amyloidosis who had blood samples collected within 30 days of diagnosis were 
seen at the Mayo Clinic. Rochester, Mn. Troponin levels were determined and related to 
survival. 
Results: cTnT (Roche) was elevated in 63% and cTnl (Dade) in 88% of patients. Median 
survival was 6 months in patients with elevated cTnT and 9 months with elevated cTnl. 
Patients with undetectable levels had median suwival of 21 months. Multivariate analysis 
demonstrated cTnT was the most powedul predictor of mortality, providing a continuous 
distribution of risk. Prognostication improved still further when the troponin data were 
added to age and IV septal wall thickness. 
Conclusion: Elevated serum troponin levels, particularly cTnT, detected early after the 
diagnosis of PSA predict cardiac involvement and a poor short-term prognosis. Their 
measurement should aid in determining prognosis and therefore, the appropriateness of 
therapeutic mtewentions. 
1160-79 Impact of Microangiopathy on Left Ventricular 
Remodeling and Clinical Outcome in Cardiac 
Sarcoidosis Patients Treated With Corticosteroids: A 
Long-Term Echocardiographic Follow-Up Study 
Yoshikazu Yazaki, Kamiyoshi Yuichi, Kaoru Koaashi, Osamu Yokoseki, Hiroshi 
Imamura, Hiroaki Takenaka, Mafumt Owa, Minoru Hongo, K&hi Kubo, Marie Sekiguchi. 
Shinshu University, Matsumoto, Japan 
Background: Micmangiopathy presenting as basal lamina layering around the microvas- 
culature (BLL) detected by electron microscopy is often observed in various tissues 
affected by sarcoidosis, including the heart. Although microangiopathy may be related to 
disease process in sarcoidosis, the clinical significance is unknown in cardiac sarcoidosls 
(CS). Methods: To investigate the clinical significance of microanglopathy, we analyzed 
the clinicopathological findings and long-term outcome in consecutive 16 CS patients in 
whom ultra structural observations of hearl btopsy specimens were performed. Sarcoido- 
sis was confirmed histologically in all patients from the lung, skin, lymphnode or heart 
We also underwent serial echocardiographic assessment over 5 years. Results: Granu- 
lomas were confirmed in only 3 patients (20%) by endomyocardial biopsy. Multiple BLL 
(5 layers) was found in 9 patients (group A), but the other 7 patients showed a few or no 
BLL (group B). The group A patients showed a lower left ventricular (LV) ejection fraction 
compared to the group 6 patients (39 f 13% vs. 59 + 23%, ~~0.05). Percent area of 
interstitial fibrosis measured by morphometry in the group A patients was significantly 
greater than that in the group B patients (17 f 10% vs. 8 + 5%, p-zO.05). A cardiac event 
(worsening heart failure requinng hospitalization. sustained ventricular tachycardia, or 
cardiac death) occurred in 6 group A patients (67%) and 1 group B patient (14%) during 
the mean follow-up period of 66 months (p<O.O5), and 5 group A patients (56%) died. 
Despite corticosteroid treatment, group A patients showed a significant increase in LV 
volume index (78 * 2lmllm2 to 103 f 23mllm2. ~~0.01) and decrease in wall thickness 
of the interventricular septum (12 f 4mm to 9 f 3mm, pcO.01) over 5.year follow-up, 
although there was no significant change in LV ejection fraction and ventricular mass. No 
group B patient died, and echocardiographic parameters were unchanged in this group. 
Conclusion: Microangiopathy may be related to ventricular remodeling, disease progres- 
sion, and poor clinical outcome in cases of CS. 
1160-80 Myocardial Infiltration in Sarcoidosis Demonstrated 
With Delayed Contrast Enhanced Magnetic Resonance 
Imaging 
Robert J. van Geuns Jan P. Smedema, Peter Pattynama. Piotr A. Wielopolski, Pim J. de 
Feyter, Erasmus MC, Rotterdam. The Netherlands 
Background: 
Cardiac involvement in sarcoidosis is clinically diagnosed in 5% of patients, although it 
can be demonstrated at autopsy in 20 to 30 per cent of cases. It can lead to significant 
morbidity and mortality, and early diagnosis may improve outcome. EchocardIography 
may demonstrate systolic and diastolic left ventricular dysfunction, but not demonstrate 
more subtle, early changes. Delayed contrast enhanced inversion recovery magnetic 
resonance Imaging provides a larger contrast between normal and injured myocardium in 
the setting of acute myocardial infarction. This technique may be also more sensitive to 
demonstrated cardiac Infiltration in sarcoidosis before left ventricular dysfunction 
appears. 
Methods: 
Nineteen patients with recently diagnosed extracardiac sarcoidosis were studied wth a 
Tl-sensitive (inversion recovery) gradient echo sequence (TE = 3.4 msec, TR = RR 
interval, inversion time 250 ms) before and after the administration after a Tl shorting 
contrast agent (0.1 mmollkg Gd-DTPA, Magnevist, Shering, Berlin). Additionally tine 
gradient echo Images in short- and long-axis orientations where obtained to evaluated 
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1161-59 The Relationship Between Diabetes Mellitus and the 
Chronotropic Index in the Prediction of Cardiac Death 
Babak Azarbal Sean W. Hayes, Rory Hachamovitch. Daniel S. Berman, Cedars-Sinai 
Medical Center, Los Angeles, CA 
Background: Diabetes mellitus (DM) and impaired heart rate response to exercise, 
measured by chronotropic index (Cl), are predictors of cardiac death (CD). Also, pts with 
DM often have autonomic dysfunction. We studied the relationship between DM and Cl 
in pts undergoing exercise mywardial perfusion SPECT (MPS). 
Methods 10,830 consecutive pts without valvular disease and not onp blockers under- 
went symptom-limited exercise MPS; 609 pts were censored for early revascularization 
(~60 d). Cl = (peak HR rest HR)/(Z:PO-age-rest HR), with ClcO.8 defined as low. Sulvwal 
modeling was performed. 
Results 93 CD occurred during a follow-up of 719 * 252 days (98% complete). Of 
10,021 pts, 1085 (11%) had DM and 2956 (30%) had low Cl. Pts with DM were more 
likely to have a low Cl (46% vs. 27%, pcO.OOl).After adjusting for age, sex, family history 
of CAD, exercise duration, and MPS defect severity, Cl was predictwe and interacted sig- 
nificantly with DM (p=O.O48). Adjusted survival by of Cl and DM is shown in the Fig: A: 
pts with Cm.8/no DM: B: ClX8/DM; C: ClcO.8/no DM; D: Cl<0,8/DM. 
In pts with CUl.8, DM did not increase risk compared to non-DM (Hazard Ratio=1 .O. 0.4- 
2.7). In pts with Cl<O.8, nsk was doubled in non-DM (HazR=P.O, 1.2-3.1) and was even 
higher in DM (HazR=3.4. 1.9-6.4). 
Conclusion: Cl and DM Interact significantly and dlabetlcs frequently have low Cl. 
